Qing Guo

Qing Guo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
WQWeijing Qi
Weijing Qi
YLYan Liu
Yan Liu
HLHuicong Lv
Huicong Lv
JGJun Ge
Jun Ge
YMYucui Meng
Yucui Meng
JHJie Hu
Jie Hu
Background: Numerous studies suggest that interpersonal relationships and social support influence the development of postpartum depression and sleep quality for women. However, the effect of support from the husband or the mother-in-law has not been thoroughly validated. The current study examined the relative contribution of marital satisfaction, perceived caring of the mother-in-law, and social support on postpartum depression and sleep quality simultaneously in a path model. Methods: A cross-sectional study was conducted from March to June 2017 in Hebei, China, using a self-report questionnaire. A total of 817 women participated at 6 weeks postpartum. Sociodemographics and information about marital satisfaction, perceived caring of the mother-in-law, social support, postpartum depression, and sleep were collected. Path analysis was used to analyze the cross-sectional data. Results: The final model had a highly satisfactory fit. Marital satisfaction and perceived caring of mother-in-law had both direct and indirect effects on postpartum depression through social support, but these two variables had only an indirect effect on sleep quality through social support and postpartum depression. Sleep quality is a consequence of postpartum depression at 6 weeks after delivery. The prevalence of minor and major postpartum depressive symptoms at 6 weeks postpartum was 41.49 and 23.13%, respectively. A total of 371 (45.41%) women experienced sleep disturbance at 6 weeks postpartum. Conclusions: These findings suggest that interpersonal relationships with family members play important roles in postpartum depression and sleep quality through social support in Chinese women. Improving the relationship between new mothers and their husbands or mothers-in-law and then enhancing social support might reduce postpartum depression and sleep disturbance.

7 March 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WQWeijing Qi
Weijing Qi
YWYongjian Wang
Yongjian Wang
YWYipeng Wang
Yipeng Wang
SHSha Huang
Sha Huang
CLCong Li
Cong Li
JHJie Hu
Jie Hu
Postpartum depression (PPD) is a significant public health issue. This study aimed to develop and validate machine learning (ML) models using biopsychosocial predictors to predict the risk of PPD for perinatal women and to provide several risk assessment tools for the early detection of PPD. Candidate predictors, including history of mental illness and demographic, psychosocial, and physiological factors, were obtained from 1138 perinatal women between August 2021 and August 2022. The primary outcome of PPD was measured with the Edinburgh Postnatal Depression Scale at 6 weeks postpartum. Seven feature selection methods and six ML algorithms were employed to develop models, and their prediction performances were compared. A total of 11 potential predictive factors associated with PPD were identified and subsequently used to construct prenatal and postpartum predictive models for PPD. The cross-validation results showed that the models built on logistic regression (LR) [area under the curve (AUC): 0.801, 0.858] and artificial neural network (ANN) (AUC: 0.787, 0.844) algorithms exhibited the best prediction performance. In contrast to the prenatal models, the addition of postpartum predictors (primary caregiver and mother-in-law’s care) remarkably improved the predictive performance of the postpartum models. The risk-stratification score, the nomogram, and the Shapley additive explanation were used to visualize and interpret the risk prediction model for predicting PPD in the early stage. The LR and ANN models achieved the best predictive performances. Applying these models and risk assessment tools to early predict and screen PPD has several implications for public health.

25 November 2015 in Oncology Research
Verified
Journal Article
Open access
QGQing Guo
Qing Guo
BGBu-Lang Gao
Bu-Lang Gao
XZXue-Jing Zhang
Xue-Jing Zhang
GLGuo-Chao Liu
Guo-Chao Liu
FXFeng Xu
Feng Xu
XWXiao-Hua Wu
Xiao-Hua Wu
The CXCL12-CXCR4 chemokine axis may play a very important role in ovarian cancer cells proliferation, migration, invasion, and peritoneal metastasis in vitro and in vivo. In this study, transfected SKOV3-CXCR4, transfected vector SKOV3-negative, nontransfected SKOV3 ovarian cancer cells, and human peritoneal mesothelial cells (HPMCs) were cultivated in vitro, and the proliferation, migration, and invasion of these ovarian cancer cells were investigated with or without the influence of the CXCL12-CXCR4 axis. Nude mice models of ovarian cancer were created by injection of ovarian cancer cells into the peritoneal cavity for investigation of ovarian cancer cells metastasis. Our results demonstrated that in the SKOV3-CXCR4 group, the cell number of proliferation, migration, or penetration through the Matrigel membrane treated with CXCL12 was significantly (p < 0.05) greater than those treated with CXCR4 antibody or CXCR4 antagonist AMD 3100 in a concentration-dependent manner. In the SKOV3-negative and the nontransfected SKOV3 groups, no significant (p > 0.05) differences existed in the cell number of proliferation, migration, or penetration. Coculture of HPMCs and SKOV3-CXCR4 had significantly (p < 0.05) higher migration and invasion rates than the SKOV3-CXCR4-only group. In nude mice seeded with ovarian cancer cells, the tumor weight in the nude mice injected with SKOV3-CXCR4 cells was significantly (p < 0.05) greater than in the group injected with the SKOV3-negative or nontransfected SKOV3 cells. Taken together, our results show that the CXCL12-CXCR4 chemokine axis can significantly promote the proliferation, migration, invasion, and peritoneal metastasis of ovarian cancer cells, and interference with this axis may serve as a new therapeutic target in treating ovarian cancers.

7 August 2021 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Open access
PDF file
KHKe He
Ke He
QGQing Guo
Qing Guo
JGJun Ge
Jun Ge
JLJingxin Li
Jingxin Li
CLCaixia Li
Caixia Li
ZJZeng Jing
Zeng Jing
What is known and objective: Pregnant women are increasingly being exposed to metformin for conditions including gestational diabetes mellitus and type 2 diabetes mellitus. Metformin has been found to exhibit maternal to foetal transfer, and the long-term influence is uncertain. We conducted a meta-analysis to compare the efficacy and safety of metformin alone or as add-on therapy to insulin and insulin in pregnancy with gestational diabetes mellitus or type 2 diabetes mellitus. Methods: We performed a comprehensive literature search of PubMed, Embase, Cochrane Library and ClinicalTrials.gov for randomized controlled trials (RCTs) that compared metformin to insulin in pregnancy. Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were used to synthesize the results. Two authors independently extracted the data, evaluated study quality and calculated pooled estimates. Results: Twenty-one studies involving 4,545 patients were included in this meta-analysis. Compared with insulin, metformin significantly reduced the risks of maternal weight gain [MD −1.51 kg, 95%CI (−1.90 kg, −1.12 kg), P < 0.00001], gestational age at birth [MD −0.12 week, 95%CI (−0.21 week, −0.02 week), P = 0.02], gestational hypertension [RR 0.63, 95%CI (0.48, 0.82), P = 0.0006], maternal hypoglycaemia [RR 0.33, 95%CI (0.15, 0.73), P = 0.006], birthweight [MD −0.13 kg, 95%CI (−0.20 kg, −0.07 kg), P < 0.0001], neonatal hypoglycaemia [RR 0.56, 95%CI (0.49, 0.64), P < 0.00001], neonatal intensive care unit admission [RR 0.73, 95%CI (0.64, 0.83), P < 0.00001], birthweight ≥4000 g [RR 0.70, 95%CI (0.59, 0.83), P < 0.0001], and large for gestational age [RR 0.83, 95%CI (0.72, 0.97), P = 0.02] and significantly increased the risk of small for gestational age [RR 1.43, 95%CI (1.08, 1.89), P = 0.01] in pregnancy. What is new and conclusion: Metformin may have potential benefits for pregnant women and newborns in terms of maternal and foetal outcomes. More studies with long-term follow-up of offspring exposed to metformin in utero are needed to provide evidence for the future use of metformin in pregnancy.

11 October 2018 in International Journal of Hyperthermia
Verified
Journal Article
Open access
QGQing Guo
Qing Guo
FXFeng Xu
Feng Xu
ZDZhenzhen Ding
Zhenzhen Ding
PLPan Li
Pan Li
XWXinghai Wang
Xinghai Wang
BGBu-Lang Gao
Bu-Lang Gao
Objective: To compare the treatment efficacy and safety of high intensity focused ultrasound (HIFU) on its own, HIFU combined with levonorgestrel-releasing intrauterine system (LNG-IUS) and HIFU combined with gonadotropin-releasing hormone agonist (GnRHa). Method: Seventy-eight patients with adenomyosis who underwent HIFU treatment were retrospectively analyzed. Among them, 45 patients were treated only with HIFU, 15 patients were treated with HIFU combined with LNG-IUS and 18 patients were treated with HIFU combined with GnRHa. Dysmenorrhea scores, menstrual blood volumes, uterine volumes and adenomyotic lesion volumes were evaluated 1, 6 and 12 months after HIFU. Result: After treatment, dysmenorrhea score, menstrual blood volume, uterine volume and adenomyotic lesion volume significantly decreased in all three groups (p < 0.05). No significant difference was observed among the HIFU group, HIFU with LNG-IUS group and HIFU with GnRHa group 1 month after HIFU. However, 6 and 12 months after HIFU, dysmenorrhea score, menstrual blood volume, uterine volume and adenomyotic lesion volume decreased significantly more in the HIFU with LNG-IUS group and HIFU with GnRH-a group than in the group treated with HIFU on its own (p < 0.05). Conclusion: HIFU can be effectively used in the management of adenomyosis. Based on the results of this study with a limited number of patients, our study suggested that combining HIFU with LNG-IUS or GnRHa may provide a superior clinical effect compared to HIFU treatment on its own.

19 April 2023 in Journal of Affective Disorders
Verified
Journal Article
Closed access
WQWeijing Qi
Weijing Qi
YWYongjian Wang
Yongjian Wang
CLCaixia Li
Caixia Li
KHKe He
Ke He
YWYipeng Wang
Yipeng Wang
JHJie Hu
Jie Hu